William B. Walkup & Associates’s Eli Lilly LLY Stock Holding History

William B. Walkup & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.76M	Sell	2,298 -9	-0.4%	-$9.2K	1.33%	20
2026 Q1	$1.91M	Hold	2,307	–	–	1.14%	25
2025 Q4	$2.48M	Hold	2,307	–	–	1.36%	20
2025 Q3	$1.76M	Hold	2,307	–	–	0.94%	28
2025 Q2	$1.8M	Hold	2,307	–	–	1.06%	27
2025 Q1	$1.91M	Buy	2,307 +7	+0.3%	+$5.83K	1.16%	24
2024 Q4	$1.78M	Hold	2,300	–	–	1.12%	23
2024 Q3	$2.04M	Sell	2,300 -35	-1%	-$31.5K	1.26%	22
2024 Q2	$2.11M	Buy	+2,335	New	+$1.87M	1.38%	23

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

William B. Walkup & Associates's LLY Position: Q2 2026 in Review

William B. Walkup & Associates reduced its Eli Lilly (LLY) stake by 0.39% in Q2 2026, selling an estimated $9.2K and leaving 2,298 shares worth $2.76M. The position accounts for 1.33% of the portfolio, ranked #20.

William B. Walkup & Associates first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

William B. Walkup & Associates held 2,298 shares of Eli Lilly worth $2.76M as of Q2 2026.
William B. Walkup & Associates sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
Eli Lilly made up 1.33% of William B. Walkup & Associates's portfolio in Q2 2026, its #20 holding.
William B. Walkup & Associates first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.